StockData
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW

Sunshine Biopharma Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.24+0.02 (+9.02%)

Close on Oct 19, 2026

Market cap
$330.14K
P/E (TTM)
–
Dividend yield
–

Sunshine Biopharma Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Sunshine Biopharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.